← Back to all trials
Active Not Recruiting
NCT07663175
Safety and Efficacy of Intensified Chemotherapy Regimens in Aggressive B-cell Lymphomas With MYC Rearrangement.
Conditions: B-cell Lymphomas With MYC Rearrangement
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 500
Sponsor: IRCCS San Raffaele
Location: IRCCS Ospedale San Raffaele Milan Italy
Summary
A multicenter, retrospective, observational drug study using anonymized data from adult patients with aggressive B-cell lymphoma treated with the CARMEN regimen.
The data were collected during normal clinical practice, therefore neither diagnostic approaches nor experimental drugs/devices will be applied.
Eligibility Criteria
Inclusion Criteria:
* Age \> 18 years
* Histology of aggressive B-cell lymphoma with MYC rearrangement
* Treatment with CARMEN regimen orwith other chemoimmunotherapy regimens for treatment of aggressive B-cell lymphoma with MYC rearrangement
Exclusion Criteria:
* Participation in clinical protocols that expressly exclude the possibility of participation in other studies
Source: ClinicalTrials.gov (NCT07663175). StuddyBuddy aggregates publicly available trial information.
